Literature DB >> 16251538

The medical management of depression.

J John Mann1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251538     DOI: 10.1056/NEJMra050730

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  88 in total

Review 1.  [Depressive disorders. A diagnostic and therapeutic challenge also for primary care].

Authors:  H-P Kapfhammer
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

2.  Transfer of the antidepressant mirtazapine into breast milk.

Authors:  J H Kristensen; Kenneth F Ilett; Jonathan Rampono; Rolland Kohan; L Peter Hackett
Journal:  Br J Clin Pharmacol       Date:  2006-09-13       Impact factor: 4.335

3.  Mirtazapine to reduce methamphetamine use: a randomized controlled trial.

Authors:  Grant N Colfax; Glenn-Milo Santos; Moupali Das; Deirdre McDermott Santos; Tim Matheson; James Gasper; Steve Shoptaw; Eric Vittinghoff
Journal:  Arch Gen Psychiatry       Date:  2011-11

4.  Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.

Authors:  Alexandra Deschwanden; Beata Karolewicz; Anteneh M Feyissa; Valerie Treyer; Simon M Ametamey; Anass Johayem; Cyrill Burger; Yves P Auberson; Judit Sovago; Craig A Stockmeier; Alfred Buck; Gregor Hasler
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

5.  Role of depression in outcomes of endoscopic sinus surgery.

Authors:  Jamie R Litvack; Jess Mace; Timothy L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2011-02-01       Impact factor: 3.497

6.  Pathophysiology of depression: do we have any solid evidence of interest to clinicians?

Authors:  Gregor Hasler
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

Review 7.  Duloxetine: a review of its use in the treatment of major depressive disorder.

Authors:  James E Frampton; Greg L Plosker
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.

Authors:  Jennifer S Rabin; Zahra Shirzadi; Walter Swardfager; Bradley J MacIntosh; Aaron Schultz; Hyun-Sik Yang; Rachel F Buckley; Jennifer R Gatchel; Dylan Kirn; Jeremy J Pruzin; Trey Hedden; Nir Lipsman; Dorene M Rentz; Sandra E Black; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal
Journal:  Neurobiol Aging       Date:  2020-03-07       Impact factor: 4.673

9.  Selective serotonin reuptake inhibitor sertraline inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.

Authors:  Han Sol Kim; Hongliang Li; Hye Won Kim; Sung Eun Shin; Il-Whan Choi; Amy L Firth; Hyoweon Bang; Young Min Bae; Won Sun Park
Journal:  J Biosci       Date:  2016-12       Impact factor: 1.826

10.  Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Authors:  Matthew S Milak; Ramin V Parsey; Leilani Lee; Maria A Oquendo; Doreen M Olvet; Francoise Eipper; Kevin Malone; J John Mann
Journal:  Psychiatry Res       Date:  2009-05-14       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.